全文获取类型
收费全文 | 36960篇 |
免费 | 2037篇 |
国内免费 | 205篇 |
专业分类
耳鼻咽喉 | 409篇 |
儿科学 | 675篇 |
妇产科学 | 338篇 |
基础医学 | 4829篇 |
口腔科学 | 988篇 |
临床医学 | 2637篇 |
内科学 | 9220篇 |
皮肤病学 | 619篇 |
神经病学 | 2751篇 |
特种医学 | 1407篇 |
外科学 | 6026篇 |
综合类 | 217篇 |
一般理论 | 2篇 |
预防医学 | 1260篇 |
眼科学 | 561篇 |
药学 | 3060篇 |
中国医学 | 77篇 |
肿瘤学 | 4126篇 |
出版年
2023年 | 252篇 |
2022年 | 434篇 |
2021年 | 952篇 |
2020年 | 467篇 |
2019年 | 654篇 |
2018年 | 814篇 |
2017年 | 656篇 |
2016年 | 743篇 |
2015年 | 763篇 |
2014年 | 965篇 |
2013年 | 1153篇 |
2012年 | 1712篇 |
2011年 | 1866篇 |
2010年 | 1038篇 |
2009年 | 882篇 |
2008年 | 1546篇 |
2007年 | 1558篇 |
2006年 | 1539篇 |
2005年 | 1615篇 |
2004年 | 1526篇 |
2003年 | 1477篇 |
2002年 | 1505篇 |
2001年 | 1245篇 |
2000年 | 1384篇 |
1999年 | 1228篇 |
1998年 | 456篇 |
1997年 | 344篇 |
1996年 | 338篇 |
1995年 | 294篇 |
1994年 | 276篇 |
1993年 | 270篇 |
1992年 | 806篇 |
1991年 | 726篇 |
1990年 | 736篇 |
1989年 | 780篇 |
1988年 | 712篇 |
1987年 | 641篇 |
1986年 | 609篇 |
1985年 | 573篇 |
1984年 | 449篇 |
1983年 | 334篇 |
1982年 | 191篇 |
1980年 | 163篇 |
1979年 | 285篇 |
1978年 | 222篇 |
1977年 | 172篇 |
1974年 | 166篇 |
1973年 | 152篇 |
1971年 | 153篇 |
1969年 | 171篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
Hiroto Kinoshita Hitomi Nishioka Aya Ikeda Kyoko Ikoma Yoichi Sameshima Hidehisa Ohi Mizuki Tatsuno Junka Kouyama Chiaki Kawamoto Tomohiro Mitsui Yuko Tamura Yu Hashimoto Masashi Nishio Tsuyoshi Ogashiwa Yusuke Saigusa Shin Maeda Hideaki Kimura Reiko Kunisaki Kazuhiko Koike 《Journal of gastroenterology and hepatology》2019,34(11):1929-1939
6.
7.
8.
Marie Ohata Susumu Fujiwara Ai Yoshioka Hiroshi Nagai Shintaro Sugita Nozomi Yamano Yusuke Inoue Chikako Nishigori 《Pediatric dermatology》2019,36(6):997-998
Fibroblastic connective tissue nevus (FCTN) is a benign cutaneous mesenchymal lesion characterized by proliferation of CD34‐positive fibroblastic/myofibroblastic spindle‐shaped cells. We report a case of agminated FCTN on the right lower abdomen of a 1‐year‐old boy. 相似文献
9.
Kayoko Minakata Masako Suzuki Hideki Nozawa Kunio Gonmori Kanako Watanabe Osamu Suzuki 《Forensic Toxicology》2006,24(2):83-87
Platinum (Pt) levels were determined in various tissues and body fluids obtained from a patient who died 181 days after cisplatin
overdosing. The symptoms of cisplatin overdose, however, might have almost disappeared by day 40, and the patient’s death
was ascribed to the recurrence of malignant lymphoma. Determination of Pt derived from cisplatin was performed by electrospray
ionization mass spectrometry (ESI-MS) using silver (Ag) as internal standard. Pt and Ag complexed with diethyldithiocarbamate
(DDC) in wetashed blood, and tissue solutions were extracted into isoamyl alcohol, and then acidified with oxalic acid. By
injecting an aliquot of the isoamyl alcohol layer into a mass spectrometer in the direct flow injection mode, the quantitation
was performed using the signals of Pt(DDC)3
+ and Ag(DDC)2
+ at m/z 639 and 403, respectively. The Pt levels ranged from 25ng/ml in blood to 2050ng/g wet weight in the liver of the patient,
indicating that Pt remained at high levels in tissues, even after a period as long as 181 days after cisplatin overdosing. 相似文献
10.
Kazunori Aizawa Takeshi Hanaoka Hiroki Kasai Kaoru Kogashi Setsuo Kumazaki Jun Koyama Hiroshi Tsutsui Yoshikazu Yazaki Noboru Watanabe Osamu Kinoshita Uichi Ikeda 《Hypertension research》2006,29(2):123-128
The phosphodiesterase-5 (PDE-5) inhibitor, sildenafil, has been reported to produce sustained pulmonary vasodilatation in patients with pulmonary hypertension (PH). Recently, vardenafil, a more potent and selective PDE-5 inhibitor than sildenafil, has been approved for the treatment of erectile dysfunction. However, the long-term effects of oral vardenafil in patients with PH are unknown. We studied five consecutive patients with PH; one with primary pulmonary hypertension, two with chronic pulmonary thromboembolism, one with Eisenmenger syndrome (ventricular septal defect) and one with secondary pulmonary hypertension after a ventricular septal defect closure operation. In an acute hemodynamic trial, vardenafil (5 mg) significantly decreased both the pulmonary vascular resistance (PVR) and systemic vascular resistance (SVR) with an increase in cardiac output. In a chronic hemodynamic trial, the maintenance dose of vardenafil (10 to 15 mg) for 3 months significantly decreased the PVR, but not the SVR, with a 20.7% reduction of the PVR/ SVR ratio. Plasma brain natriuretic peptide (BNP) levels were also significantly decreased after 3 months. This pilot study demonstrates that long-term oral vardenafil therapy may be a safe and effective treatment for patients with PH. 相似文献